We are live on
!
Find out more
CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
15 hedge funds and large institutions have $1.58M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$168K | |
| 2 | +$1.83K | |
| 3 | +$1.1K | |
| 4 |
CG
Colony Group
Boston,
Massachusetts
|
+$610 |
| 5 |
BBPWM
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
|
+$12 |
Top Sellers
| 1 | -$326K | |
| 2 | -$48.8K | |
| 3 | -$35.7K | |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$31.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$10.6K |